Today: 9 June 2026
Reddit stock (RDDT) slips after CTO share-sale filing; traders weigh AI-citation thesis
31 December 2025
1 min read

Reddit stock (RDDT) slips after CTO share-sale filing; traders weigh AI-citation thesis

NEW YORK, December 30, 2025, 21:26 ET — Market closed.

  • Reddit closed down 0.55% at $233.36 in New York trading
  • An SEC filing showed CTO Christopher Slowe sold 14,000 shares under a Rule 10b5-1 plan
  • Needham reiterated a Buy and a $300 target, citing Reddit’s prominence in AI-generated answers

Reddit, Inc. (RDDT) shares slipped 0.55% on Tuesday to close at $233.36 after a showed its chief technology officer sold shares.

The pullback landed in a holiday-thin stretch of trading, when fresh headlines can move growth stocks more than usual. Investors are also trying to pin down whether Reddit can turn its growing role in AI-powered search and chatbots into steadier advertising and data-licensing revenue.

Needham reiterated a Buy rating and a $300 price target on Monday, pointing to what it described as Reddit’s “AI citation dominance” — how often its communities show up as sources in AI-generated answers.

Reddit swung between $229.08 and $236.93, with about 2.48 million shares changing hands. The stock was last quoted at $232.65 in extended trading, according to .

Christopher Slowe sold 14,000 shares on Dec. 22 for about $3.27 million at weighted-average prices ranging from $231.49 to $240.10, the filing showed. He also exercised options and ended with 171,694 shares held directly after the transactions.

The trades were executed under a Rule 10b5-1 plan — a pre-set trading schedule that lets insiders buy or sell stock at set times rather than making discretionary trades.

Needham analyst Laura Martin said Reddit is “a key source of information for large language models,” the AI systems behind chatbots and search assistants, according to InvestorsObserver.

A that tracked citations across ChatGPT, Google’s AI Mode and Perplexity found Reddit among the most-cited domains, while also showing that citation patterns can swing sharply over short periods.

U.S. stocks ended modestly lower, with the S&P 500 down 0.14% and the Nasdaq off 0.23% as traders digested Fed minutes and positioned into year-end. (See Reuters market wrap .)

Minutes from the Federal Reserve’s Dec. 9-10 meeting showed officials were divided after a quarter-point cut that lowered the benchmark rate to a 3.5%–3.75% range.

For advertisers, Reddit competes for budgets with larger social platforms such as Meta Platforms and Snap, while its AI visibility is increasingly compared with content-heavy sites like Wikipedia and YouTube.

Before the next session on Wednesday — the final trading day of 2025 — traders will watch whether thin liquidity keeps amplifying moves in momentum names like Reddit. Tuesday’s low near $229 is a level short-term traders are likely to monitor.

The next macro tests come in early January, with December jobs and consumer-price data due Jan. 9 and Jan. 13 and the Fed’s next meeting scheduled for Jan. 27-28, Reuters reported in its minutes story . Investing.com lists Feb. 18, 2026 as Reddit’s next earnings date , putting the focus on ad demand and any monetization tied to AI-driven discovery.

Stock Market Today

  • AmpliTech Shares Surge 26.7% on 5G Open RAN Testing Update
    June 9, 2026, 9:16 AM EDT. AmpliTech (AMPG) shares surged 26.7% to $6.57 following its Open RAN testing update at the O-RAN Alliance Global PlugFest Spring 2026. The company's 64T64R Massive MIMO radio, which uses multiple antennas to enhance wireless capacity, was the only one of its kind tested with equipment from major operators including AT&T and Deutsche Telekom. Despite the strong test results, no new sales orders were announced, leaving investors cautious about future revenue impact. AmpliTech reported a 48.6% increase in first-quarter revenue to $5.35 million but remains unprofitable, narrowing its net loss to $1.52 million. The firm holds $18.4 million in cash and securities. Open RAN aims to enable multi-vendor interoperability in 5G networks, a critical push in telecom infrastructure modernization.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop